LeMaitre Vascular Reddick Scoop Tip Cholangiogram Catheter (eIFU) REF# e2401-50
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot Number/Ex p. Date: RST2390 2018-08 RST2393 2018-09 RST2396 2018-10 RST2397 2018-10 RST2398 2018-10 RST2401 2018-12 RST2402 2018-12 RST2418 2019-02 RST2420 2019-03 RST2423 2019-03 RST2428 2019-04 RST2432 2019-04 RST2433 2019-04 RST2437 2019-06 RST2438 2019-06 RST2441 2019-07
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
β οΈ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- LeMaitre Vascular, Inc.
- Reason for Recall:
- The Contains Latex symbol was not printed onto the box label or the sterile (inner) product pouch
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
LeMaitre Vascular Reddick Scoop Tip Cholangiogram Catheter (eIFU) REF# e2401-50
Product Codes/Lot Numbers:
Lot Number/Ex p. Date: RST2390 2018-08 RST2393 2018-09 RST2396 2018-10 RST2397 2018-10 RST2398 2018-10 RST2401 2018-12 RST2402 2018-12 RST2418 2019-02 RST2420 2019-03 RST2423 2019-03 RST2428 2019-04 RST2432 2019-04 RST2433 2019-04 RST2437 2019-06 RST2438 2019-06 RST2441 2019-07
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: Z-1446-2017
Related Recalls
ArtegraftΒΏ Collagen Vascular Graft; REF: AG1015;
LeMaitre Vascular
The device was incorrectly packed in the wrong size labeled outer packaging.
Devices were distributed with incorrect label without CE and UKCA mark, missing patient leaflet and patient implant card.
The bovine carotid arteries used to produce the impacted grafts from affected lots were sourced using raw material from a supplier that had not been reviewed and approved by the appropriate regulatory authority.